Phase II Trial of the Superenhancer Inhibitor Minnelide in Advanced Refractory Adenosquamous Carcinoma of the Pancreas (ASCP)
Summary
The purpose of this phase II trial is to evaluate the safety and efficacy of Minnelide in patients with adenosquamous carcinoma.
General Information
NCT#: NCT04896073
Study ID: 10000254
Trial Phase: Phase II
Trial Sponsor: National Cancer Institute (NCI)
Therapies Used in This Trial: Minnelide™